AYRA GROUP PTY. LTD – Trademark Portfolio

Entity Type: 99

AYRA GROUP PTY. LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OCTOPUS. The owner is based in Sydney.

Level 2/11 York Street

Sydney NSW2000 , AU

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OCTOPUS
OCTOPUS
Registered 2022
OCTOPUS
OCTOPUS
Registered 2022

Trademark Classifications

AYRA GROUP PTY. LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does AYRA GROUP PTY. LTD have?

AYRA GROUP PTY. LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does AYRA GROUP PTY. LTD file in?

AYRA GROUP PTY. LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.

What are AYRA GROUP PTY. LTD's most well-known trademarks?

AYRA GROUP PTY. LTD's registered trademark portfolio includes well-known marks such as OCTOPUS. These are among 2 currently registered trademarks in the portfolio.

What is AYRA GROUP PTY. LTD's trademark registration success rate?

AYRA GROUP PTY. LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.